BioXcel Therapeutics Agrees To Teva Asset Sale
(RTTNews) - BioXcel Therapeutics Inc. (BTAI) on Friday entered into an agreement to sell substantially all of its assets to Teva Pharmaceuticals International GmbH (TEVA.TA) and filed for voluntary Chapter 11 bankruptcy.
(RTTNews) - BioXcel Therapeutics Inc. (BTAI) on Friday entered into an agreement to sell substantially all of its assets to Teva Pharmaceuticals International GmbH (TEVA.TA) and filed for voluntary Chapter 11 bankruptcy.
BELLINGS Intelligence Score: 15
Why it matters
The sale of BioXcel Therapeutics' assets to Teva amid a Chapter 11 filing is a company-specific restructuring event with limited broader credit-market impact or systemic relevance.
Sources
Nasdaq
BioXcel Therapeutics Agrees To Teva Asset Sale
(RTTNews) - BioXcel Therapeutics Inc. (BTAI) on Friday entered into an agreement to sell substantially all of its assets to Teva Pharmaceuticals International GmbH (TEVA.TA) and filed for voluntary Chapter 11 bankruptcy.